{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:56:32Z","timestamp":1783133792019,"version":"3.54.6"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Arterial hypertension is considered a risk factor for the development of heart failure. Here we investigate cross-sectional associations of systolic and diastolic blood pressure with subtle functional and morphological changes of left ventricular echocardiographic parameters representing early dysfunction in three representative German population-based studies. We assessed 26,719 individuals without symptomatic heart failure from the Hamburg City Health Study (HCHS, n\u2009=\u20097396, derivation cohort), the Gutenberg Health Study (GHS, 14,715, validation cohort) and the Study of Health in Pomerania (SHIP, 4608, validation cohort). Multivariable linear regression analyses with systolic and diastolic blood pressure as continuous exposure variables were adjusted for common cardiovascular risk factors and antihypertensive medication. Both systolic and diastolic blood pressure were consistently associated with measures of left ventricular hypertrophy (\u03b2 per standard deviation (SD) for LV mass (g) and systolic blood pressure: 5.09 (p\u2009&lt;\u20090.001); diastolic blood pressure: 2.29 (p\u2009&lt;\u20090.001) in HCHS). Systolic blood pressure correlated with declining diastolic function (\u03b2 per SD for E\/e\u2032: 0.29, p\u2009&lt;\u20090.001 in HCHS) and diastolic blood pressure with declining systolic function (\u03b2 per SD for LVEF, in %: \u2212\u00a00.15; p\u2009=\u20090.041 in HCHS) in all cohorts. Pending further validation, our results from three independent German population samples suggest differential effects of systolic versus diastolic blood pressure on left ventricular structure and function.<\/jats:p>","DOI":"10.1038\/s41598-023-41571-x","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T12:46:42Z","timestamp":1693831602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Correlation of systolic and diastolic blood pressure with echocardiographic phenotypes of cardiac structure and function from three German population-based studies"],"prefix":"10.1038","volume":"13","author":[{"given":"Julius","family":"Nikorowitsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Bei der Kellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Haack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Magnussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Prochaska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp S.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Twerenbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate B.","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello Ricardo Paulista","family":"Markus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Per","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"41571_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"B Zhou","year":"2021","unstructured":"Zhou, B. et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398, 957\u2013980 (2021).","journal-title":"Lancet"},{"key":"41571_CR2","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/HJH.0b013e3282fe1d3d","volume":"26","author":"G Tocci","year":"2008","unstructured":"Tocci, G., Sciarretta, S. & Volpe, M. Development of heart failure in recent hypertension trials. J. Hypertens. 26, 1477\u20131486 (2008).","journal-title":"J. Hypertens."},{"key":"41571_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.275.20.1557","author":"D Levy","year":"1996","unstructured":"Levy, D., Larson, M. G., Vasan, R. S., Kannel, W. B. & Ho, K. K. L. The progression from hypertension to congestive heart failure. J. Am. Med. Assoc. https:\/\/doi.org\/10.1001\/jama.275.20.1557 (1996).","journal-title":"J. Am. Med. Assoc."},{"key":"41571_CR4","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1161\/hy1101.098549","volume":"38","author":"B L\u00f3pez","year":"2001","unstructured":"L\u00f3pez, B. et al. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 38, 1222\u20131226 (2001).","journal-title":"Hypertension"},{"key":"41571_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.118.11125","volume":"72","author":"A Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez, A. et al. Myocardial remodeling in hypertension toward a new view of hypertensive heart disease. Hypertension 72, 549\u2013558 (2018).","journal-title":"Hypertension"},{"key":"41571_CR6","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1097\/HJH.0b013e328308da55","volume":"26","author":"MRP Markus","year":"2008","unstructured":"Markus, M. R. P. et al. Implications of persistent prehypertension for ageing-related changes in left ventricular geometry and function: The MONICA\/KORA Augsburg study. J. Hypertens. 26, 2040\u20132049 (2008).","journal-title":"J. Hypertens."},{"key":"41571_CR7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.mcna.2004.06.002","volume":"88","author":"JLJ Izzo","year":"2004","unstructured":"Izzo, J. L. J. & Gradman, A. H. Mechanisms and management of hypertensive heart disease: From left ventricular hypertrophy to heart failure. Med. Clin. North Am. 88, 1257\u20131271 (2004).","journal-title":"Med. Clin. North Am."},{"key":"41571_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2008.141","author":"GW Yip","year":"2009","unstructured":"Yip, G. W., Fung, J. W. H., Tan, Y. T. & Sanderson, J. E. Hypertension and heart failure: A dysfunction of systole, diastole or both?. J. Hum. Hypertens. https:\/\/doi.org\/10.1038\/jhh.2008.141 (2009).","journal-title":"J. Hum. Hypertens."},{"key":"41571_CR9","doi-asserted-by":"publisher","first-page":"e016009","DOI":"10.1161\/JAHA.119.016009","volume":"9","author":"F-F Wei","year":"2020","unstructured":"Wei, F.-F. et al. Associations of left ventricular structure and function with blood pressure in heart failure with preserved ejection fraction: Analysis of the TOPCAT trial. J. Am. Heart Assoc. 9, e016009 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"41571_CR10","doi-asserted-by":"publisher","first-page":"e0157493","DOI":"10.1371\/journal.pone.0157493","volume":"11","author":"E Maksuti","year":"2016","unstructured":"Maksuti, E., Westerhof, N., Westerhof, B. E., Broom\u00e9, M. & Stergiopulos, N. Contribution of the arterial system and the heart to blood pressure during normal aging\u2014A simulation study. PLoS ONE 11, e0157493 (2016).","journal-title":"PLoS ONE"},{"key":"41571_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.110.979203","volume":"124","author":"CSP Lam","year":"2011","unstructured":"Lam, C. S. P. et al. Cardiac and non-cardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation 124, 24 (2011).","journal-title":"Circulation"},{"key":"41571_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10654-019-00577-4","volume":"35","author":"A Jagodzinski","year":"2020","unstructured":"Jagodzinski, A. et al. Rationale and design of the Hamburg City Health Study. Eur. J. Epidemiol. 35, 169\u2013181 (2020).","journal-title":"Eur. J. Epidemiol."},{"key":"41571_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ije\/dyp394","volume":"40","author":"H V\u00f6lzke","year":"2011","unstructured":"V\u00f6lzke, H. et al. Cohort profile: The study of health in Pomerania. Int. J. Epidemiol. 40, 294\u2013307 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"41571_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00103-012-1502-7","volume":"55","author":"PS Wild","year":"2012","unstructured":"Wild, P. S. et al. The Gutenberg Health Study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55, 824\u2013829 (2012).","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"41571_CR15","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams, B. et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 39, 3021\u20133104 (2018).","journal-title":"Eur. Heart J."},{"key":"41571_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur. Hear. J. Cardiovasc. Imaging 16, 233\u2013271 (2015).","journal-title":"Eur. Hear. J. Cardiovasc. Imaging"},{"key":"41571_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","volume":"102","author":"BH Lorell","year":"2000","unstructured":"Lorell, B. H. & Carabello, B. A. Left ventricular hypertrophy: Pathogenesis, detection, and prognosis. Circulation 102, 470\u2013479 (2000).","journal-title":"Circulation"},{"key":"41571_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002693","author":"BM Kaess","year":"2016","unstructured":"Kaess, B. M. et al. Relations of central hemodynamics and aortic stiffness with left ventricular structure and function: The Framingham Heart Study. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.115.002693 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"41571_CR19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-1-200301070-00006","author":"AW Haider","year":"2003","unstructured":"Haider, A. W., Larson, M. G., Franklin, S. S. & Levy, D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann. Intern. Med. https:\/\/doi.org\/10.7326\/0003-4819-138-1-200301070-00006 (2003).","journal-title":"Ann. Intern. Med."},{"key":"41571_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1803180","volume":"381","author":"AC Flint","year":"2019","unstructured":"Flint, A. C. et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N. Engl. J. Med. 381, 243\u2013251 (2019).","journal-title":"N. Engl. J. Med."},{"key":"41571_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.004876","author":"Y Li","year":"2014","unstructured":"Li, Y. et al. Ambulatory hypertension subtypes and 24-hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations. Circulation https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.004876 (2014).","journal-title":"Circulation"},{"key":"41571_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1524-6175.2001.00827.x","volume":"3","author":"G de Simone","year":"2001","unstructured":"de Simone, G. & Palmieri, V. Diastolic dysfunction in arterial hypertension. J. Clin. Hypertens. 3, 22\u201327 (2001).","journal-title":"J. Clin. Hypertens."},{"key":"41571_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014547","author":"AJS Webb","year":"2020","unstructured":"Webb, A. J. S. Progression of arterial stiffness is associated with midlife diastolic blood pressure and transition to late-life hypertensive phenotypes. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.119.014547 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"41571_CR24","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.jacc.2016.07.754","volume":"68","author":"JW McEvoy","year":"2016","unstructured":"McEvoy, J. W. et al. Diastolic blood pressure, subclinical myocardial damage, and cardiac events: Implications for blood pressure control. J. Am. Coll. Cardiol. 68, 1713\u20131722 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"41571_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.21402","author":"JW McEvoy","year":"2020","unstructured":"McEvoy, J. W. et al. Association of isolated diastolic hypertension as defined by the 2017 ACC\/AHA blood pressure guideline with incident cardiovascular outcomes. JAMA J. Am. Med. Assoc. https:\/\/doi.org\/10.1001\/jama.2019.21402 (2020).","journal-title":"JAMA J. Am. Med. Assoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41571-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T05:41:13Z","timestamp":1700545273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41571-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41571"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-41571-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"2 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JPW reports research funding from the <i>Deutsche Stiftung f\u00fcr<\/i> Herzforschung unrelated to the current work. PK is listed as inventor on two patents held by University of Birmingham (Atrial Fibrillation Therapy WO 2015140571, Markers for Atrial Fibrillation WO 2016012783). PK receives additional research support for basic, translational, and clinical research projects from European Union, British Heart Foundation, Leducq Foundation, Medical Research Council (UK), and German Centre for Cardiovascular Research, from several drug and device companies active in atrial fibrillation, and has received honoraria from several such companies in the past, but not in the last three years. CM has received speaker fees from AstraZeneca, Novartis, Loewenstein Medical, Boehringer Ingelheim\/Lilly, Bayer, Pfizer, Sanofi, Aventis, Apontis, Abbott outside this work. RT holds a professorship in clinical cardiology at the University Medical Center Hamburg-Eppendorf, supported by the K\u00fchne Foundation, and reports research support from the German Center for Cardiovascular Research (DZHK), the Swiss National Science Foundation (Grant No P300PB_167803), the Swiss Heart Foundation and the Swiss Society of Cardiologyand speaker honoraria\/consulting honoraria from Abbott, Amgen, Astra Zeneca, Roche, Siemens, Singulex and Thermo Scientific BRAHMS, outside the submitted work. No other authors declare potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14525"}}